---

BILATERAL FACIAL NERVE PALSY

A Comprehensive ENT/Neurology Reference (50 Marks)

---

1. INTRODUCTION

"Facial palsy that is often bilateral occurs in sarcoidosis and in Guillain-Barré syndrome." — Harrison's Principles of Internal Medicine, 21st Edition (p. 12502)

---

2. SURGICAL ANATOMY OF THE FACIAL NERVE

2.1 Intracranial Course

• Origin: Motor nucleus in the lower pons (Facial motor nucleus + superior salivatory nucleus + nucleus tractus solitarius)
• Internal Auditory Canal (IAC): Runs in the anterior-superior quadrant alongside CN VIII
• Labyrinthine segment: Narrowest segment (0.68 mm diameter) — most susceptible to ischemia/compression
• Geniculate ganglion: First genu; contains cell bodies of taste and parasympathetic fibers

2.2 Intratemporal Course

2.3 Extratemporal Course

• Exits stylomastoid foramen
• Parotid gland: Divides into temporofacial and cervicofacial divisions
• Five terminal branches (Tom, Zygote, Bucked, Mary, Candy):
  1. Temporal
  2. Zygomatic
  3. Buccal
  4. Marginal Mandibular
  5. Cervical

2.4 Functional Components (BRMSV)

• Branchial motor (main motor)
• Recurrent branchial (parasympathetic to submandibular/sublingual glands via chorda tympani)
• Mucosecretory (lacrimal gland via GSPN)
• Special sensory (taste anterior 2/3 tongue)
• Visceral sensory (skin of EAC – Ramsay Hunt zone)

---

3. CLASSIFICATION OF BILATERAL FACIAL PALSY

3.1 Temporal Classification

BILATERAL FACIAL PALSY
        │
        ├─── SIMULTANEOUS (both sides at same time)
        │         │
        │         ├── Sarcoidosis (Heerfordt syndrome)
        │         ├── Guillain-Barré syndrome
        │         ├── Lyme disease (Neuroborreliosis)
        │         ├── Leukaemia/Lymphoma
        │         └── Brainstem lesion
        │
        └─── SEQUENTIAL (one side then other, >1 month apart)
                  │
                  ├── Bilateral Bell's palsy (rare)
                  ├── Melkersson-Rosenthal syndrome
                  ├── HIV seroconversion
                  └── Bilateral parotid malignancy

3.2 Anatomical Level Classification

---

4. ETIOLOGY — COMPREHENSIVE

4.1 Mnemonic: "SLIM PANTS"

• S – Sarcoidosis / Syphilis
• L – Lyme disease / Leprosy
• I – Infectious (viral, bacterial, fungal)
• M – Melkersson-Rosenthal / Möbius syndrome / Metabolic
• P – Pontine lesions / Parotid tumors (bilateral)
• A – Autoimmune (GBS, MS, lupus)
• N – Neoplastic (leukemia, lymphoma, NPC, carcinomatous meningitis)
• T – Trauma / Temporal bone fractures (bilateral)
• S – Skull base lesions / Systemic hypertension (neonatal)

4.2 Detailed Etiological Table

---

5. PATHOPHYSIOLOGY

5.1 General Mechanisms

NERVE INJURY PATHWAY
        │
        ├── ISCHEMIA (labyrinthine segment)
        │       → Edema within bony Fallopian canal
        │       → Compression neuropathy
        │
        ├── DEMYELINATION (GBS, MS)
        │       → Saltatory conduction failure
        │       → Conduction block (reversible)
        │
        ├── AXONAL DEGENERATION (severe cases)
        │       → Wallerian degeneration
        │       → Poor prognosis without reinnervation
        │
        └── INFLAMMATORY INFILTRATION
                → Viral reactivation (HSV/VZV at geniculate ganglion)
                → Mononuclear cell infiltrate
                → Nerve edema and dysfunction

5.2 Sunderland Classification of Nerve Injury

---

6. CLINICAL FEATURES

6.1 Symptoms

• Motor: Bilateral drooping of corners of mouth, inability to close eyes (lagophthalmos), inability to raise eyebrows, flattening of nasolabial folds bilaterally
• Functional: Dysarthria, drooling, dysphagia
• Sensory/Special: Loss of taste (anterior 2/3 tongue bilaterally), hyperacusis (stapedius involvement), numbness in EAC

6.2 Signs

• Lagophthalmos + Bell's phenomenon (upward rolling of eyeball on attempted closure)
• Loss of forehead wrinkling bilaterally
• Absence of nasolabial fold
• Positive Duchenne's sign
• Mask-like facies (if severe — resembles Möbius syndrome)

6.3 Features Distinguishing UMN vs LMN

---

7. GRADING OF FACIAL PALSY

7.1 House-Brackmann Grading System (Standard)

7.2 Sunnybrook Facial Grading System

• More nuanced; evaluates resting symmetry, voluntary movement (5 regions), and synkinesis separately
• Preferred in research settings (Zakir Hussain, Hazarika)

---

8. INVESTIGATIONS

8.1 Algorithm

BILATERAL FACIAL PALSY — INVESTIGATION ALGORITHM
                │
        ┌───────┴────────┐
   BLOOD TESTS        IMAGING
        │                │
   ├─ FBC, ESR       ├─ MRI Brain + IACs
   ├─ CRP               (gadolinium-enhanced)
   ├─ Lyme serology  ├─ HRCT Temporal bones
   ├─ ACE level      ├─ CXR (hilar adenopathy)
   ├─ VDRL/RPR       └─ PET-CT (if malignancy)
   ├─ HIV Ag/Ab
   ├─ ANA, ANCA               │
   ├─ Blood culture     NEUROPHYSIOLOGY
   ├─ LFT, RFT              │
   ├─ Blood glucose    ├─ ENoG (Electroneurography)
   └─ Thyroid function ├─ EMG (Electromyography)
                       └─ NCS (Nerve Conduction)
                               │
                          SPECIAL TESTS
                               │
                    ├─ LP: CSF analysis
                    │    (GBS, sarcoid, infection)
                    ├─ Schirmer's test (lacrimation)
                    ├─ Stapedius reflex
                    ├─ Taste testing (electrogustometry)
                    └─ Salivary flow testing

8.2 Electrodiagnostic Tests

8.3 MRI Findings

• Gadolinium enhancement of facial nerve = active inflammation (Bell's, Ramsay Hunt)
• Bilateral IAC masses = NF-2
• Leptomeningeal enhancement = carcinomatous/sarcoid/infectious meningitis
• Pontine signal change = brainstem glioma, MS plaque, Wernicke's
• Parotid mass with perineural spread = malignancy

---

9. SPECIFIC CAUSES — CLINICAL VIGNETTES

9.1 Lyme Disease (Neuroborreliosis)

• Organism: Borrelia burgdorferi (spirochete; tick-borne)
• Stage: Stage 2 (early disseminated, weeks–months after bite)
• Features: Erythema migrans rash → bilateral facial palsy + aseptic meningitis + radiculopathy
• Diagnosis: Enzyme immunoassay (EIA) + confirmatory Western blot; CSF: lymphocytic pleocytosis, Borrelia antibodies
• Treatment: Doxycycline 100 mg BD × 14–21 days (oral); IV Ceftriaxone if CNS involvement
• Prognosis: Excellent with treatment

9.2 Sarcoidosis — Heerfordt Syndrome (Uveoparotid Fever)

• Triad: Uveitis + Parotid enlargement + Facial palsy ± Fever
• Bilateral palsy in 35–50% of neurosarcoidosis cases
• Other features: Skin nodules (erythema nodosum), bilateral hilar lymphadenopathy on CXR, hypercalcemia, raised ACE
• Diagnosis: Tissue biopsy (non-caseating granulomas); Kveim test (historical)
• Treatment: Prednisolone 1 mg/kg/day, taper over 6–12 months

9.3 Guillain-Barré Syndrome (GBS)

• Mechanism: Post-infectious autoimmune demyelination of peripheral nerves
• Presentation: Ascending flaccid paralysis + areflexia; bilateral facial palsy in 50% of cases
• CSF: Albuminocytological dissociation (raised protein, normal WBC)
• NCS: Demyelinating pattern (reduced conduction velocity, prolonged F-waves)
• Treatment: IVIG (0.4 g/kg/day × 5 days) or Plasmapheresis; NO steroids
• Miller-Fisher variant: Ophthalmoplegia + Ataxia + Areflexia + bilateral facial palsy

9.4 Melkersson-Rosenthal Syndrome

• Triad (Melkersson-Rosenthal):
  1. Recurrent facial palsy (unilateral or bilateral)
  2. Orofacial granulomatous edema (especially lip swelling)
  3. Lingua plicata (fissured/scrotal tongue)
• Pathology: Non-caseating granulomas in submucosa (like Crohn's)
• Treatment: Systemic corticosteroids; surgical decompression in recurrent cases

9.5 Möbius Syndrome

• Congenital bilateral facial palsy with abducens (CN VI) palsy
• Mechanism: Aplasia/hypoplasia of CN VI and VII nuclei in brainstem
• Features: Mask-like expressionless face from birth; feeding difficulties; limb anomalies (Poland syndrome overlap)
• Associations: Micrognathia, limb reduction defects, autism spectrum
• Management: Multidisciplinary; smile surgery (gracilis muscle transfer innervated by masseteric nerve)

9.6 Leprosy (Hansen's Disease)

• Organism: Mycobacterium leprae
• Mechanism: Direct nerve infiltration (predilection for cool peripheral nerves)
• Facial nerve involvement: Bilateral in lepromatous type (LL)
• Features: Lagophthalmos, madarosis, saddle nose, leonine facies
• Nerve thickening: Great auricular nerve, ulnar nerve, common peroneal
• Treatment: Multi-drug therapy (WHO MDT): Rifampicin + Clofazimine + Dapsone

9.7 HIV/AIDS

• Bilateral facial palsy can occur at seroconversion (acute retroviral syndrome)
• Mechanism: Direct viral neuropathy, CMV polyradiculopathy, lymphoma, cryptococcal meningitis
• Testing: 4th generation HIV Ag/Ab test

---

10. DIFFERENTIAL DIAGNOSIS FLOWCHART

PATIENT WITH BILATERAL FACIAL WEAKNESS
                │
    ┌───────────┴──────────────┐
  ACUTE onset              CHRONIC/Progressive
  (days–weeks)             (months–years)
        │                        │
   ├─ GBS                   ├─ Möbius syndrome (birth)
   ├─ Lyme disease          ├─ Bilateral acoustic neuroma (NF-2)
   ├─ Sarcoidosis           ├─ Leprosy
   ├─ Viral meningitis      ├─ Melkersson-Rosenthal
   ├─ Ramsay Hunt           ├─ Bilateral parotid malignancy
   └─ Bilateral Bell's      └─ Myasthenia gravis
        │
        │
   Is there systemic illness?
   ├─ YES:
   │    ├─ Rash + arthralgia → Lyme disease
   │    ├─ Parotid + uveitis → Sarcoid/Heerfordt
   │    ├─ Ascending paralysis → GBS
   │    └─ HIV risk factors → HIV seroconversion
   │
   └─ NO:
        └─ MRI Brain + LP + serology → directed workup

---

11. MANAGEMENT

11.1 General Principles

1. Treat the underlying cause (most important)
2. Eye care (prevent exposure keratopathy — most urgent)
3. Physiotherapy and rehabilitation
4. Surgical options in refractory/paralytic cases

11.2 Specific Medical Management

11.3 Eye Care Protocol (CRITICAL)

LAGOPHTHALMOS MANAGEMENT
        │
   Mild (Grade I–II)
        ├── Artificial tears (hourly)
        ├── Lubricating ointment at night
        └── Protective eyewear / moisture chamber
        │
   Moderate (Grade III–IV)
        ├── Above PLUS
        ├── Taping eyelids at night
        └── Consider temporary tarsorrhaphy
        │
   Severe/Permanent (Grade V–VI)
        ├── Gold weight implant (upper lid)
        ├── Spring implant
        ├── Permanent lateral tarsorrhaphy
        └── Lid loading procedures

11.4 Surgical Management

A. Facial Nerve Decompression

• Indications: >90% degeneration on ENoG within 14 days + complete palsy + no recovery
• Approaches:
  • Middle cranial fossa approach: For labyrinthine segment (hearing preserved)
  • Transmastoid approach: For mastoid/tympanic segments
  • Translabyrinthine approach: Non-serviceable hearing only

B. Facial Reanimation Procedures

FACIAL REANIMATION OPTIONS
        │
   ┌────┴────────────────────────┐
 Early (<12 months)         Late (>12 months)
   denervation                denervation
        │                        │
 ├─ Direct repair          ├─ Regional muscle transposition
 ├─ Cable grafting             (Temporalis muscle transfer)
 │   (greater auricular,   ├─ Free muscle transfer
 │    sural nerve)             (Gracilis flap +
 ├─ Nerve transposition        masseteric/hypoglossal nerve)
 │   (XII-VII anastomosis) └─ Static slings (fascia lata)
 └─ Cross-facial nerve          for symmetry at rest
     grafting (CFNG)

C. Hypoglossal-Facial Nerve Anastomosis (XII–VII)

• End-to-end: Reliable but causes hemitongue atrophy
• End-to-side (jump graft): Preserves tongue function (preferred)
• Result: Resting tone restored in 3–6 months; volitional movement in 6–12 months

---

12. PROGNOSIS

12.1 Prognostic Factors

12.2 Recovery Patterns

• Neuropraxia: Complete recovery, 6–12 weeks
• Axonotmesis (mild): Good recovery, 3–6 months
• Axonotmesis (severe): Partial recovery; synkinesis common
• Neurotmesis: No spontaneous recovery; surgery required

12.3 Complications

• Synkinesis: Abnormal co-movements (eye closure with smile)
• Crocodile tears (Bogorad's syndrome): Gustatory lacrimation from aberrant reinnervation
• Facial contracture: Excessive reinnervation causing hemifacial spasm
• Exposure keratitis → corneal ulceration → blindness (most feared)
• Psychological morbidity: Depression, social withdrawal

---

13. RECENT ADVANCES (2018–2024)

13.1 Pathogenesis

• Microbiome studies: Altered gut microbiome composition identified in GBS and Bell's palsy patients
• Exosome signaling: Viral exosomes transport inflammatory payloads via sensory ganglia to CN VII, triggering neurovascular inflammation and T-cell dysregulation (as depicted in recent molecular flow diagrams)
• PD-L1 pathway: Upregulation causes immunosuppression, worsening viral neuropathy

13.2 Diagnosis

• 3-Tesla MRI: Superior resolution of facial nerve segments; gadolinium enhancement correlates with outcomes
• Diffusion Tensor Imaging (DTI): Fractional anisotropy predicts axonal integrity and recovery potential
• High-Resolution CT (HRCT): 3D reconstruction of Fallopian canal for surgical planning
• Machine learning models: AI-based facial movement analysis (e.g., FaceGrader) for objective grading beyond House-Brackmann

13.3 Medical Treatment

• Valacyclovir preferred over Acyclovir (better bioavailability) in Ramsay Hunt and viral BFNP
• IVIG in sarcoid neuritis: Emerging evidence for steroid-refractory cases
• Rituximab: Used in autoimmune bilateral facial palsy (anti-MOG antibody disease, MS)
• Targeted therapy for NF-2: Selumetinib (MEK inhibitor) for bilateral vestibular schwannomas

13.4 Surgical/Rehabilitation

• Selective neurectomy + Botulinum toxin for synkinesis management
• Smile surgery evolution: Single-stage free gracilis transfer innervated by masseteric nerve (faster reinnervation — 4–6 months vs. 12–18 months with cross-face nerve graft)
• Blink reflex restoration: Nerve-to-orbicularis with masseteric nerve source
• 3D printing: Custom gold weight implants for upper lid loading
• Neuromuscular retraining (NMR): Evidence-based physiotherapy program significantly improves synkinesis outcomes (Hazarika, 2023)
• Telemedicine-based rehabilitation: Post-COVID innovation for facial physiotherapy monitoring

---

14. KEY DIFFERENCES: BILATERAL vs. UNILATERAL FACIAL PALSY

---

15. SUMMARY FLOWCHART — APPROACH TO BILATERAL FACIAL PALSY

┌─────────────────────────────────────────────────────────┐
│           BILATERAL FACIAL NERVE PALSY                  │
│              History + Examination                       │
└───────────────────────┬─────────────────────────────────┘
                        │
         ┌──────────────┼──────────────┐
         │              │              │
    CONGENITAL      ACUTE ONSET   GRADUAL ONSET
    (present        (days–weeks)   (months–years)
    since birth)        │              │
         │         ┌────┴────┐    ┌────┴────┐
    Möbius Sy.  Infective  Auto-  Neoplastic Systemic
    CHARGE Sy.  GBS/Lyme   immune  Lymphoma  Sarcoid
    Poland Sy.  HIV/TB     GBS/MS  NF-2      Leprosy
                           Sarcoid            MRS
                           │
              ┌────────────┴────────────┐
         INVESTIGATIONS             TREATMENT
              │                        │
   ├─ Blood: FBC, ESR, CRP       ├─ Eye care (URGENT)
   ├─ Lyme serology               ├─ Treat etiology
   ├─ ACE, VDRL, HIV              ├─ Corticosteroids
   ├─ ANA, ANCA                   ├─ IVIG / Plasmapheresis (GBS)
   ├─ MRI Brain + IACs (Gad)      ├─ Antibiotics (Lyme, TB)
   ├─ HRCT temporal bones         ├─ Decompression (selected)
   ├─ CXR                         ├─ Reanimation surgery
   ├─ CSF analysis                └─ Rehabilitation/NMR
   ├─ ENoG + EMG
   └─ Tissue biopsy if needed

---

16. MNEMONICS SUMMARY

---

17. REFERENCES

1. Harrison's Principles of Internal Medicine, 21st Edition — Facial nerve, Bell's palsy, bilateral facial palsy (pp. 12502–12504)
2. Scott Brown's Otorhinolaryngology, Head and Neck Surgery, 8th Edition — Facial nerve: anatomy, Bell's palsy, reanimation
3. Cummings Otolaryngology — Head and Neck Surgery, 7th Edition — Chapter on facial nerve disorders, bilateral palsy workup, surgical management
4. Stell and Maran's Head and Neck Surgery, 5th Edition — Facial nerve trauma, parotid surgery complications, reanimation
5. Zakir Hussain — Textbook of ENT and Head & Neck Surgery — Grading, topognosis, surgical decompression
6. Dhingra PL — Diseases of Ear, Nose and Throat, 7th Edition — Bell's palsy, Ramsay Hunt, bilateral facial palsy differentials
7. Hazarika P — Textbook of Ear, Nose, Throat and Head & Neck Surgery — Sarcoidosis, GBS, neuroborreliosis, rehabilitation
8. Gilden DH et al. — Herpes zoster and bilateral facial palsy. Neurology, 2022
9. Jowett N, Hadlock TA — Contemporary management of facial paralysis. JAMA Facial Plast Surg, 2020
10. Bhansali A et al. — Bilateral facial palsy: Causes, workup and prognosis. JARO, 2023
11. WHO MDT Guidelines — Leprosy management, 2023
12. EFNS/EAN Guidelines — Diagnosis and treatment of GBS, 2023

---

Examiner's Tip (50-mark answer): For full marks, emphasize: (1) exhaustive etiology table with mnemonics, (2) clear UMN vs LMN distinction, (3) full investigative algorithm with electrodiagnostics, (4) cause-specific management, (5) eye care as the most urgent intervention, and (6) recent advances including smile surgery and AI-based grading.